Correlation Between Ryanair Holdings and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ryanair Holdings and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ryanair Holdings and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ryanair Holdings PLC and Carmell Therapeutics, you can compare the effects of market volatilities on Ryanair Holdings and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ryanair Holdings with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ryanair Holdings and Carmell Therapeutics.
Diversification Opportunities for Ryanair Holdings and Carmell Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ryanair and Carmell is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Ryanair Holdings PLC and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Ryanair Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ryanair Holdings PLC are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Ryanair Holdings i.e., Ryanair Holdings and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Ryanair Holdings and Carmell Therapeutics
Assuming the 90 days horizon Ryanair Holdings is expected to generate 22.85 times less return on investment than Carmell Therapeutics. But when comparing it to its historical volatility, Ryanair Holdings PLC is 10.31 times less risky than Carmell Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Carmell Therapeutics on September 14, 2024 and sell it today you would lose (10.21) from holding Carmell Therapeutics or give up 68.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 34.2% |
| Values | Daily Returns |
Ryanair Holdings PLC vs. Carmell Therapeutics
Performance |
| Timeline |
| Ryanair Holdings PLC |
| Carmell Therapeutics |
Ryanair Holdings and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ryanair Holdings and Carmell Therapeutics
The main advantage of trading using opposite Ryanair Holdings and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ryanair Holdings position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Ryanair Holdings vs. Allegiant Travel | Ryanair Holdings vs. Azul SA | Ryanair Holdings vs. Alaska Air Group | Ryanair Holdings vs. International Consolidated Airlines |
| Carmell Therapeutics vs. Ryanair Holdings PLC | Carmell Therapeutics vs. BJs Restaurants | Carmell Therapeutics vs. Dine Brands Global | Carmell Therapeutics vs. United Guardian |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |